Cargando…

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease

The characteristic brain pathology and motor and nonmotor symptoms of Parkinson's disease (PD) are well established. However, the details regarding the causes of the disease and its course are much less clear. Animal models have significantly enriched our current understanding of the progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dongping, Xu, Jing, Wang, Jinghui, Tong, Jiabin, Bai, Xiaochen, Li, Heng, Wang, Zishan, Huang, Yulu, Wu, Yufei, Yu, Mei, Huang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555011/ https://www.ncbi.nlm.nih.gov/pubmed/28831326 http://dx.doi.org/10.1155/2017/9349487

Ejemplares similares

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2021)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson’s disease
por: Ruan, Sisi, et al.
Publicado: (2023)

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP(+) and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
por: Guo, Xingfang, et al.
Publicado: (2019)

Deficiency of miR-29b2/c leads to accelerated aging and neuroprotection in MPTP-induced Parkinson’s disease mice
por: Bai, Xiaochen, et al.
Publicado: (2021)

Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models
por: Wang, Zishan, et al.
Publicado: (2020)

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
por: Kopaeva, Marina Yu., et al.
Publicado: (2021)

Transgenic supplementation of SIRT1 fails to alleviate acute loss of nigrostriatal dopamine neurons and gliosis in a mouse model of MPTP-induced parkinsonism
por: Kitao, Yasuko, et al.
Publicado: (2015)

Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
por: Mannino, Deborah, et al.
Publicado: (2023)

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
por: Wi, Rayul, et al.
Publicado: (2020)

NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
por: Liu, Zhaolin, et al.
Publicado: (2023)

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
por: Liu, Jie, et al.
Publicado: (2015)

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
por: Ma, Chunmei, et al.
Publicado: (2023)

Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
por: Bai, Xiaochen, et al.
Publicado: (2017)

Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse
por: Song, Lian-Kun, et al.
Publicado: (2015)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
por: Du, Guangwei, et al.
Publicado: (2012)

Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model
por: Villadiego, Javier, et al.
Publicado: (2023)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
por: Wang, Jing, et al.
Publicado: (2020)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Microglia reaction on the neurotoxic effect of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the nigrostriatal pathway in mice
por: Czlonkowska, A., et al.
Publicado: (1994)

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
por: Wang, Li-Yuan, et al.
Publicado: (2019)

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease()
por: Ziegler, Erik, et al.
Publicado: (2014)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse
por: Heng, Yang, et al.
Publicado: (2022)

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism
por: Chang, Chiung-Chih, et al.
Publicado: (2016)

TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease
por: Shao, Qian-hang, et al.
Publicado: (2019)

SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway
por: Liu, Lei, et al.
Publicado: (2014)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu, Shanshan, et al.
Publicado: (2020)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota
por: Zhou, Xiaoting, et al.
Publicado: (2021)

Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
por: Gou, De-Hai, et al.
Publicado: (2020)

Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway
por: Wang, Li, et al.
Publicado: (2021)

Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models
por: Kurtenbach, Stefan, et al.
Publicado: (2013)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson’s Disease
por: De Nuccio, Francesco, et al.
Publicado: (2021)

A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson’s disease
por: Tang, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4dtl27r9g1ettufd125349ri5